Revenue
2022
2023
2024
2025
Bioventix plc (BVXP)
Price£17.05Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | £13.1M | £13.6M | £12.8M | £11.7M |
| Research & development | — | — | −£25,243 | −£22,160 |
| Operating expenses | £1.8M | £2.1M | £1.9M | £1.8M |
| Operating income | £10.1M | £10.6M | £10.1M | £9.2M |
| Operating margin | 76.80% | 78.10% | 78.57% | 78.34% |
| EBITDA | £10.2M | £10.7M | £10.2M | £9.4M |
| EBITDA margin | 77.51% | 78.93% | 79.58% | 80.40% |
| Net income | £7.6M | £8.1M | £8.4M | £7.7M |
| Net profit margin | 57.83% | 59.51% | 65.33% | 65.48% |
| Basic EPSper basic share | £1.45 | £155.12 | £1.61 | £1.47 |
| Diluted EPSper diluted share | £1.43 | £152.86 | £1.58 | £1.46 |